Sort
30,917 grants matching “tumor microenvironment”
Understanding mechanisms of impaired immunity in the AML bone marrow
$303,621Susan E Dewolf · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA
Understanding mechanisms of impaired immunity in the AML bone marrow
$303,621Susan E Dewolf · Sloan-Kettering Inst Can Research · K08 · FY2025 · CA
Improving therapy of glioblastoma multiforme by enhancing therapeutic drug delive
$303,614Michael R McDevitt · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
HER2 regulation of luminal breast cancer stem cells
$303,594Max S. Wicha · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
P53 inactivation on MDSC development and tumor progression
$303,590Yan Cui · Augusta University · R01 · FY2014 · CA
3D Engineered Model of Microscopic Colorectal Cancer Liver Metastasis for Adjuvant Chemotherapy Screens
$303,546Shreya Raghavan · Texas Engineering Experiment Station · R37 · FY2025 · CA
Gut microbiota and inflammatory monocytes in colorectal cancer
$303,544Wendy S. Garrett · Harvard School Of Public Health · R01 · FY2011 · CA
Exploiting Cancer Metabolism and Drug Efflux with Bystander-Assisted Immunotherapy
$303,507Rock Mancini · Miami University Oxford · R01 · FY2024 · CA
Core C: Comparative Pathology Core
$303,469Enrico Radaelli · University Of Pennsylvania · P01 · FY2022 · CA
Hypoxia and Potassium Channel Activity in T Lymphocytes
$303,455Laura Conforti · University Of Cincinnati · R01 · FY2016 · CA
Micro-RNA-dependent regulation of the UPR
$303,419J. Alan Diehl · University Of Pennsylvania · P01 · FY2014 · CA
Drug Resistance in Multiple Myeloma
$303,379University Of Arizona · R01 · FY2002 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
$303,371T.-C. Wu · Johns Hopkins University · R01 · FY2012 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
$303,371T.-C. Wu · Johns Hopkins University · R01 · FY2016 · CA
Enhancing HPV-16 E6/E7 Specific Antitumor Immunity
$303,371T.-C. Wu · Johns Hopkins University · R01 · FY2015 · CA
Animal Imaging
$303,350Hongbiao Carl Lekaye · Sloan-Kettering Inst Can Research · P30 · FY2024 · CA
Hypoxia and Regulatory T cells in Cancer
$303,303Weiping Zou · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Targeting Ovarian Tumor Associated Myeloid Cells with Nanoparticles Therapeutics
$303,303Ronald J Buckanovich · University Of Michigan At Ann Arbor · R01 · FY2013 · CA
Quantitative analysis of epithelial cell scatter
$303,303Anand R Asthagiri · Northeastern University · R01 · FY2013 · CA
Personalized cancer drug repurposing using single cell RNA-Seq data
$303,258Lana X Garmire · University Of Michigan At Ann Arbor · R03 · FY2025 · OD
Project 2- The ISR effector ATF4 in metabolic reprogramming and survival during Myc-induced tumorigenesis
$303,224Constantinos Koumenis · University Of Pennsylvania · P01 · FY2019 · CA
Core 2: ImmunoPhenotyping Core
$303,215Robert H Pierce · University Of Washington · P01 · FY2019 · CA
Nanoparticle-mediated treatment for bone metastasis
$303,185Vinod D Labhasetwar · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · CA
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Protei
$303,163Stephen Lee · University Of Miami School Of Medicine · R01 · FY2015 · GM
The Nucleolar Detention Center: a Hub of Long Noncoding RNAs that Imprison Protei
$303,163Stephen Lee · University Of Miami School Of Medicine · R01 · FY2017 · GM